INTELLIGENT BIO SOLUTIONS INC. 8-K

What Happened

• Intelligent Bio Solutions Inc. (INBS) filed a Form 8-K on April 20, 2026 disclosing a Regulation FD investor presentation made available to investors that day (viewable in the Investors section at www.ibs.inc).
• The company also reported that, following warrant exercises and sales of common stock under its previously disclosed At The Market (ATM) Offering Agreement with Ladenburg Thalmann & Co. Inc., the total number of outstanding shares of common stock was 2,176,848 as of April 20, 2026 (transactions occurred since the company’s prior 8-K filed March 23, 2026).

Key Details

• Date of disclosure: April 20, 2026 (presentation made available and 8-K furnished).
• Reported outstanding common shares: 2,176,848 as of April 20, 2026.
• ATM placement agent and agreement: At The Market Offering Agreement dated September 18, 2024 with Ladenburg Thalmann & Co. Inc.
• Share count change sources: exercises of previously issued warrants and sales under the ATM program since the March 23, 2026 8-K.

Why It Matters

• Updated share count affects per‑share metrics (e.g., earnings per share, ownership percentages) and is important for assessing dilution and voting power.
• The Regulation FD investor presentation provides the company’s updated business and operational information to all investors at once; investors should review the presentation for any new guidance or strategic updates.
• Transactions under the ATM and warrant exercises are active sources of share issuance—monitor future ATM activity and corporate filings for further changes to outstanding shares.